This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paramasivan, C. N. Articles by Mitchison, D. A. Search for Related Content PubMed PubMed Citation Articles by Paramasivan, C. N. Articles by Mitchison, D. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 627-631, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.627-631.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Bactericidal Action of Gatifloxacin, Rifampin, and Isoniazid on Logarithmic- and Stationary-Phase Cultures of Mycobacterium tuberculosis

Tuberculosis Research Centre (Indian Council of Medical Research), Chennai, India,¹ St. George's Hospital Medical School, London, United Kingdom²

Received 21 July 2004/ Returned for modification 16 August 2004/ Accepted 15 October 2004

The bactericidal activity of gatifloxacin, alone and in combination with isoniazid and rifampin, was studied on both exponential- and stationary-phase cultures of Mycobacterium tuberculosis strain H37Rv. On log-phase cultures, the bactericidal activity of gatifloxacin at 4 µg/ml was rapid and was very similar to that of isoniazid. At concentrations of 0.25 and 4 µg/ml, gatifloxacin enhanced the activity of isoniazid. Killing of the stationary-phase culture was biphasic. During the first 2 days, gatifloxacin at 4 µg/ml slightly increased the limited bactericidal activities of isoniazid and rifampin. However, no further additional bactericidal activity was found during further incubation with isoniazid alone or when gatifloxacin was added to either isoniazid or rifampin. This suggested that the stationary-phase culture contained a mixture of occasionally dividing bacilli that were killed during the first 2 days and true static persisters in the residual population that mimicked those in human lesions. In view of the failure of gatifloxacin to add to the sterilizing activity of isoniazid or rifampin during days 2 to 6 of exposure in the stationary-phase culture, it is unlikely to be a sterilizing drug that can be used to shorten the duration of treatment appreciably when it is added to present treatment regimens.

This article has been cited by other articles:

• Davies, G. R., Brindle, R., Khoo, S. H., Aarons, L. J. (2006). Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatment.. Antimicrob. Agents Chemother. 50: 3154-3156 [Abstract] [Full Text]  
• Ittner, K. P., Yadav, V., Deopujari, K., Park-Wyllie, L. Y., Shah, B. R., Juurlink, D. N. (2006). Gatifloxacin and dysglycemia in older adults.. NEJM 354: 2725-2726 [Full Text]